Symbols / TIL Stock $8.13 +0.93% Instil Bio, Inc.
TIL (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Ratings
Current target
$8.13
Low
$7.00
High
$51.00
Mean
$29.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-07 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2025-09-11 | reit | HC Wainwright & Co. | Buy → Buy | $125 |
| 2025-08-27 | reit | HC Wainwright & Co. | Buy → Buy | $125 |
| 2025-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $125 |
| 2025-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $125 |
| 2025-06-02 | reit | JMP Securities | Market Perform → Market Perform | — |
| 2025-05-23 | main | HC Wainwright & Co. | Buy → Buy | $125 |
| 2025-05-22 | main | HC Wainwright & Co. | Buy → Buy | $105 |
| 2025-03-05 | reit | HC Wainwright & Co. | Buy → Buy | $110 |
| 2025-02-13 | reit | JMP Securities | Market Perform → Market Perform | — |
| 2025-01-07 | up | Jefferies | Hold → Buy | $52 |
| 2024-11-18 | reit | HC Wainwright & Co. | Buy → Buy | $110 |
| 2024-11-14 | main | HC Wainwright & Co. | Buy → Buy | $110 |
| 2024-11-04 | init | JMP Securities | — → Market Perform | — |
| 2024-09-17 | reit | HC Wainwright & Co. | Buy → Buy | $120 |
| 2024-09-16 | main | HC Wainwright & Co. | Buy → Buy | $120 |
| 2024-09-16 | reit | Baird | Outperform → Outperform | $180 |
| 2024-09-13 | main | Baird | Outperform → Outperform | $180 |
| 2024-09-12 | main | HC Wainwright & Co. | Buy → Buy | $40 |
| 2024-08-23 | main | HC Wainwright & Co. | Buy → Buy | $25 |
News
RSS: Latest TIL news- Instil Bio (NASDAQ: TIL) sets 2026 vote and replaces Deloitte - Stock Titan Fri, 24 Apr 2026 20
- Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry - Stocktwits Sat, 25 Apr 2026 17
- (TIL) and the Role of Price-Sensitive Allocations - Stock Traders Daily Sat, 25 Apr 2026 08
- TIL (Instil Bio Inc.) posts narrower Q4 2025 loss than consensus estimates, shares dip modestly in muted market reaction. - Viral Trade Signals - Cổng thông tin điện tử Tỉnh Sơn La hu, 23 Apr 2026 02
- Iovance Sarcoma Trial Data Puts TIL Platform And Stock In Focus - Yahoo Finance Sun, 08 Mar 2026 08
- Instil Bio stock falls after subsidiary discontinues AXN-2510 development - Investing.com ue, 06 Jan 2026 08
- Should You Just Buy Stocks Until You Die? - WSJ Fri, 31 Oct 2025 07
- TIL Ltd Technical Momentum Shifts Amid Bearish Outlook - Markets Mojo ue, 28 Apr 2026 03
- BrewDog assets acquisition lifts Tilray stock nearly 10 percent - Traders Union Wed, 22 Apr 2026 16
- Instil Bio (TIL) Stock Wall Street Rating (+0.11%) 2026-04-16 - Social Trading - UBND thành phố Hải Phòng hu, 16 Apr 2026 07
- After U.S. cannabis rescheduling, Tilray targets patient access - Stock Titan hu, 23 Apr 2026 12
- Why Tilray and Other Cannabis Stocks Soared on Friday? - TIKR.com Mon, 15 Dec 2025 08
- Citizens analyst reiterates Market Perform rating on Instil Bio stock - Investing.com Wed, 07 Jan 2026 08
- Instil Bio and ImmuneOnco unwind AXN-2510 pact as development stops - Stock Titan ue, 06 Jan 2026 08
- Understanding the Setup: (TIL) and Scalable Risk - Stock Traders Daily Fri, 03 Apr 2026 06
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
51.96
-7.30%
|
56.05
-35.69%
|
87.16
-57.13%
|
203.29
|
| Research And Development |
|
24.74
+108.97%
|
11.84
-70.11%
|
39.60
-71.92%
|
141.06
|
| Selling General And Administration |
|
27.22
-38.43%
|
44.21
-7.03%
|
47.55
-23.59%
|
62.23
|
| General And Administrative Expense |
|
27.22
-38.43%
|
44.21
-7.03%
|
47.55
-23.59%
|
62.23
|
| Other Gand A |
|
27.22
-38.43%
|
44.21
-7.03%
|
47.55
-23.59%
|
62.23
|
| Total Expenses |
|
51.96
-7.30%
|
56.05
-35.69%
|
87.16
-57.13%
|
203.29
|
| Operating Income |
|
-51.96
+7.30%
|
-56.05
+35.69%
|
-87.16
+57.13%
|
-203.29
|
| Total Operating Income As Reported |
|
-78.58
-6.85%
|
-73.54
+53.80%
|
-159.17
+29.71%
|
-226.46
|
| EBITDA |
|
-65.80
-5.23%
|
-62.53
+57.50%
|
-147.12
+32.32%
|
-217.38
|
| Normalized EBITDA |
|
-39.18
+13.01%
|
-45.03
+40.04%
|
-75.11
+61.33%
|
-194.21
|
| Reconciled Depreciation |
|
0.53
-85.21%
|
3.61
-24.10%
|
4.76
-20.56%
|
5.99
|
| EBIT |
|
-66.33
-0.30%
|
-66.14
+56.45%
|
-151.87
+32.01%
|
-223.37
|
| Total Unusual Items |
|
-26.62
-52.19%
|
-17.49
+75.71%
|
-72.01
-210.84%
|
-23.17
|
| Total Unusual Items Excluding Goodwill |
|
-26.62
-52.19%
|
-17.49
+75.71%
|
-72.01
-210.84%
|
-23.17
|
| Special Income Charges |
|
-26.62
-52.19%
|
-17.49
+75.71%
|
-72.01
-210.84%
|
-23.17
|
| Other Special Charges |
|
10.00
+0.00%
|
10.00
|
—
|
—
|
| Impairment Of Capital Assets |
|
16.57
+201.53%
|
5.50
-91.94%
|
68.18
|
—
|
| Restructuring And Mergern Acquisition |
|
0.05
-97.35%
|
2.00
-47.85%
|
3.83
-83.46%
|
23.17
|
| Net Income |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Pretax Income |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.70%
|
-225.25
|
| Net Non Operating Interest Income Expense |
|
-1.97
+1.70%
|
-2.00
-154.83%
|
3.66
+106.38%
|
1.77
|
| Interest Expense Non Operating |
|
5.04
-37.00%
|
8.00
+89.77%
|
4.21
+123.79%
|
1.88
|
| Net Interest Income |
|
-1.97
+1.70%
|
-2.00
-154.83%
|
3.66
+106.38%
|
1.77
|
| Interest Expense |
|
5.04
-37.00%
|
8.00
+89.77%
|
4.21
+123.79%
|
1.88
|
| Interest Income Non Operating |
|
3.86
-44.78%
|
6.99
-21.19%
|
8.87
+142.57%
|
3.65
|
| Interest Income |
|
3.86
-44.78%
|
6.99
-21.19%
|
8.87
+142.57%
|
3.65
|
| Other Income Expense |
|
-17.44
-8.46%
|
-16.08
+77.84%
|
-72.59
-205.87%
|
-23.73
|
| Other Non Operating Income Expenses |
|
9.18
+550.60%
|
1.41
+345.39%
|
-0.57
-1.95%
|
-0.56
|
| Tax Provision |
|
—
|
—
|
0.00
+100.00%
|
-2.07
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
+100.00%
|
-0.21
|
| Net Income Including Noncontrolling Interests |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Net Income From Continuing And Discontinued Operation |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Net Income Continuous Operations |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Normalized Income |
|
-44.75
+21.00%
|
-56.64
+32.63%
|
-84.08
+58.01%
|
-200.22
|
| Net Income Common Stockholders |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Diluted EPS |
|
—
|
-11.39
+52.54%
|
-24.00
+30.23%
|
-34.40
|
| Basic EPS |
|
—
|
-11.39
+52.54%
|
-24.00
+30.23%
|
-34.40
|
| Basic Average Shares |
|
—
|
6.51
+0.10%
|
6.50
+0.44%
|
6.48
|
| Diluted Average Shares |
|
—
|
6.51
+0.10%
|
6.50
+0.44%
|
6.48
|
| Diluted NI Availto Com Stockholders |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Total Other Finance Cost |
|
0.79
-20.50%
|
0.99
+0.00%
|
0.99
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
203.52
-22.78%
|
263.57
-19.06%
|
325.63
-32.46%
|
482.13
|
| Current Assets |
|
191.43
+53.80%
|
124.47
-22.57%
|
160.76
-40.32%
|
269.38
|
| Cash Cash Equivalents And Short Term Investments |
|
76.13
-32.82%
|
113.31
-24.64%
|
150.36
-42.37%
|
260.92
|
| Cash And Cash Equivalents |
|
6.64
-24.61%
|
8.80
-4.24%
|
9.20
-78.97%
|
43.72
|
| Other Short Term Investments |
|
69.49
-33.51%
|
104.51
-25.96%
|
141.16
-35.01%
|
217.20
|
| Receivables |
|
0.85
|
—
|
—
|
—
|
| Taxes Receivable |
|
0.85
|
—
|
—
|
—
|
| Prepaid Assets |
|
2.04
-78.10%
|
9.32
+4.75%
|
8.90
+5.25%
|
8.46
|
| Restricted Cash |
|
0.17
-90.93%
|
1.83
+21.92%
|
1.50
|
0.00
|
| Assets Held For Sale Current |
|
112.10
|
0.00
|
—
|
—
|
| Other Current Assets |
|
0.15
-98.41%
|
9.32
+4.75%
|
8.90
+5.25%
|
8.46
|
| Total Non Current Assets |
|
12.09
-91.31%
|
139.10
-15.63%
|
164.87
-22.50%
|
212.75
|
| Net PPE |
|
0.36
-99.72%
|
130.34
-7.61%
|
141.07
-32.61%
|
209.34
|
| Gross PPE |
|
0.75
-99.45%
|
135.12
-9.09%
|
148.63
-31.77%
|
217.82
|
| Accumulated Depreciation |
|
-0.38
+91.99%
|
-4.78
+36.74%
|
-7.55
+10.95%
|
-8.48
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
0.00
-100.00%
|
31.24
+0.00%
|
31.24
+0.00%
|
31.24
|
| Buildings And Improvements |
|
0.00
-100.00%
|
102.43
+0.00%
|
102.43
+212.51%
|
32.78
|
| Machinery Furniture Equipment |
|
0.51
+0.00%
|
0.51
-38.75%
|
0.83
-83.49%
|
5.03
|
| Construction In Progress |
|
—
|
—
|
0.00
-100.00%
|
104.12
|
| Other Properties |
|
0.24
-74.52%
|
0.93
-92.64%
|
12.70
-68.51%
|
40.31
|
| Leases |
|
—
|
0.00
-100.00%
|
1.42
-67.19%
|
4.34
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
—
|
0.00
|
| Goodwill |
|
—
|
—
|
—
|
0.00
|
| Other Intangible Assets |
|
—
|
—
|
—
|
—
|
| Investments And Advances |
|
—
|
0.00
-100.00%
|
23.16
|
0.00
|
| Non Current Accounts Receivable |
|
7.66
+79.61%
|
4.27
|
—
|
—
|
| Other Non Current Assets |
|
4.07
-9.44%
|
4.49
+602.66%
|
0.64
-81.28%
|
3.41
|
| Total Liabilities Net Minority Interest |
|
89.66
-4.75%
|
94.13
-5.68%
|
99.80
-15.80%
|
118.52
|
| Current Liabilities |
|
4.84
-38.67%
|
7.90
-25.22%
|
10.56
-67.80%
|
32.79
|
| Payables And Accrued Expenses |
|
1.95
-44.54%
|
3.52
-53.60%
|
7.59
-71.00%
|
26.18
|
| Payables |
|
0.78
+18.21%
|
0.66
-45.63%
|
1.21
-48.62%
|
2.36
|
| Accounts Payable |
|
0.78
+18.21%
|
0.66
-45.63%
|
1.21
-48.62%
|
2.36
|
| Current Accrued Expenses |
|
1.18
-58.97%
|
2.86
-55.12%
|
6.38
-73.21%
|
23.82
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
2.52
-6.47%
|
2.69
+162.28%
|
1.03
-68.65%
|
3.27
|
| Total Tax Payable |
|
—
|
—
|
—
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.37
-77.88%
|
1.68
-3.89%
|
1.75
-26.50%
|
2.38
|
| Current Capital Lease Obligation |
|
0.37
-77.88%
|
1.68
-3.89%
|
1.75
-26.50%
|
2.38
|
| Other Current Liabilities |
|
—
|
—
|
0.19
-80.04%
|
0.95
|
| Total Non Current Liabilities Net Minority Interest |
|
84.81
-1.65%
|
86.23
-3.37%
|
89.24
+4.09%
|
85.73
|
| Long Term Debt And Capital Lease Obligation |
|
84.81
-0.47%
|
85.20
+1.07%
|
84.30
+8.75%
|
77.52
|
| Long Term Debt |
|
84.81
+0.74%
|
84.19
+3.39%
|
81.43
+12.55%
|
72.35
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
1.02
-64.65%
|
2.88
-44.36%
|
5.17
|
| Non Current Deferred Liabilities |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
—
|
0.00
|
| Other Non Current Liabilities |
|
0.01
-99.22%
|
1.03
-79.12%
|
4.94
-39.88%
|
8.21
|
| Stockholders Equity |
|
113.87
-32.80%
|
169.44
-24.97%
|
225.83
-37.89%
|
363.61
|
| Common Stock Equity |
|
113.87
-32.80%
|
169.44
-24.97%
|
225.83
-37.89%
|
363.61
|
| Capital Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
6.78
+3.92%
|
6.53
+0.34%
|
6.50
0.00%
|
6.50
|
| Ordinary Shares Number |
|
6.78
+3.92%
|
6.53
+0.34%
|
6.50
0.00%
|
6.50
|
| Additional Paid In Capital |
|
840.94
+1.96%
|
824.78
+2.18%
|
807.16
+2.30%
|
788.99
|
| Retained Earnings |
|
-726.49
-10.89%
|
-655.12
-12.76%
|
-580.98
-36.74%
|
-424.89
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.58
-155.70%
|
-0.23
+34.48%
|
-0.35
+29.41%
|
-0.49
|
| Other Equity Adjustments |
|
-0.58
-155.70%
|
-0.23
+34.48%
|
-0.35
+29.41%
|
-0.49
|
| Total Equity Gross Minority Interest |
|
113.87
-32.80%
|
169.44
-24.97%
|
225.83
-37.89%
|
363.61
|
| Total Capitalization |
|
198.67
-21.67%
|
253.62
-17.46%
|
307.26
-29.52%
|
435.95
|
| Working Capital |
|
186.59
+60.06%
|
116.57
-22.39%
|
150.20
-36.51%
|
236.59
|
| Invested Capital |
|
198.67
-21.67%
|
253.62
-17.46%
|
307.26
-29.52%
|
435.95
|
| Total Debt |
|
85.18
-1.97%
|
86.89
+0.97%
|
86.05
+7.70%
|
79.90
|
| Net Debt |
|
78.17
+3.70%
|
75.38
+4.36%
|
72.23
+152.26%
|
28.63
|
| Capital Lease Obligations |
|
0.37
-86.22%
|
2.70
-41.67%
|
4.63
-38.73%
|
7.55
|
| Net Tangible Assets |
|
113.87
-32.80%
|
169.44
-24.97%
|
225.83
-37.89%
|
363.61
|
| Tangible Book Value |
|
113.87
-32.80%
|
169.44
-24.97%
|
225.83
-37.89%
|
363.61
|
| Available For Sale Securities |
|
—
|
—
|
23.16
|
—
|
| Investmentin Financial Assets |
|
—
|
0.00
-100.00%
|
23.16
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-36.62
+34.25%
|
-55.70
+32.10%
|
-82.03
+54.47%
|
-180.16
|
| Cash Flow From Continuing Operating Activities |
|
-36.62
+34.25%
|
-55.70
+32.10%
|
-82.03
+54.47%
|
-180.16
|
| Net Income From Continuing Operations |
|
-71.37
+3.73%
|
-74.14
+52.50%
|
-156.09
+30.06%
|
-223.18
|
| Depreciation Amortization Depletion |
|
0.53
-85.21%
|
3.61
-24.10%
|
4.76
-20.56%
|
5.99
|
| Depreciation |
|
0.53
-85.21%
|
3.61
-24.10%
|
4.76
-20.56%
|
5.99
|
| Depreciation And Amortization |
|
0.53
-85.21%
|
3.61
-24.10%
|
4.76
-20.56%
|
5.99
|
| Other Non Cash Items |
|
10.00
+240.52%
|
2.94
+134.54%
|
-8.50
-445.48%
|
-1.56
|
| Stock Based Compensation |
|
8.69
-49.63%
|
17.26
-5.00%
|
18.17
-40.32%
|
30.44
|
| Asset Impairment Charge |
|
16.57
+221.60%
|
5.15
-92.40%
|
67.81
+282.41%
|
17.73
|
| Operating Gains Losses |
|
-0.48
-123.18%
|
2.09
+147.39%
|
0.84
+3769.57%
|
-0.02
|
| Gain Loss On Investment Securities |
|
—
|
1.05
-8.02%
|
1.15
+181.12%
|
-1.41
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.48
-276.00%
|
0.28
+140.44%
|
-0.68
-148.89%
|
1.39
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.34
-9.02%
|
0.38
|
0.00
|
| Change In Working Capital |
|
-0.56
+95.56%
|
-12.61
-39.81%
|
-9.02
+5.75%
|
-9.57
|
| Change In Receivables |
|
-3.40
+20.39%
|
-4.27
|
—
|
—
|
| Change In Prepaid Assets |
|
6.12
+2866.97%
|
-0.22
+8.30%
|
-0.24
+43.95%
|
-0.43
|
| Change In Payables And Accrued Expense |
|
-2.23
+9.09%
|
-2.45
+72.43%
|
-8.90
+17.44%
|
-10.78
|
| Change In Accrued Expense |
|
-2.35
-23.66%
|
-1.90
+75.58%
|
-7.77
+13.41%
|
-8.98
|
| Change In Payable |
|
0.12
+120.86%
|
-0.56
+50.75%
|
-1.13
+37.49%
|
-1.81
|
| Change In Account Payable |
|
0.12
+120.86%
|
-0.56
+50.75%
|
-1.13
+37.49%
|
-1.81
|
| Change In Other Current Assets |
|
0.42
+109.74%
|
-4.36
-382.76%
|
1.54
+335.88%
|
0.35
|
| Change In Other Current Liabilities |
|
-1.47
-13.23%
|
-1.30
+8.19%
|
-1.42
-209.51%
|
1.29
|
| Investing Cash Flow |
|
25.48
-52.80%
|
53.97
+31.23%
|
41.13
-64.09%
|
114.54
|
| Cash Flow From Continuing Investing Activities |
|
25.48
-52.80%
|
53.97
+31.23%
|
41.13
-64.09%
|
114.54
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-20.66
+75.57%
|
-84.59
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-20.66
+75.57%
|
-84.59
|
| Capital Expenditure |
|
-10.00
+0.00%
|
-10.00
+51.60%
|
-20.66
+75.57%
|
-84.59
|
| Net Investment Purchase And Sale |
|
35.04
-44.47%
|
63.11
+4.77%
|
60.23
-69.75%
|
199.13
|
| Purchase Of Investment |
|
-100.86
+25.62%
|
-135.60
+55.02%
|
-301.47
+54.75%
|
-666.22
|
| Sale Of Investment |
|
135.90
-31.61%
|
198.71
-45.06%
|
361.70
-58.20%
|
865.35
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
—
|
| Purchase Of Business |
|
—
|
—
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
-10.00
+0.00%
|
-10.00
|
0.00
|
—
|
| Purchase Of Intangibles |
|
-10.00
+0.00%
|
-10.00
|
0.00
|
—
|
| Net Other Investing Changes |
|
0.43
-50.12%
|
0.87
-44.38%
|
1.56
|
—
|
| Financing Cash Flow |
|
7.29
+315.50%
|
1.75
-78.29%
|
8.08
-88.76%
|
71.89
|
| Cash Flow From Continuing Financing Activities |
|
7.29
+315.50%
|
1.75
-78.29%
|
8.08
-88.76%
|
71.89
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
2.76
-65.83%
|
8.08
-88.51%
|
70.34
|
| Issuance Of Debt |
|
0.00
-100.00%
|
85.60
+887.43%
|
8.67
-87.68%
|
70.34
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-82.84
-14012.10%
|
-0.59
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
85.60
+887.43%
|
8.67
-87.68%
|
70.34
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-82.84
-14012.10%
|
-0.59
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
2.76
-65.83%
|
8.08
-88.51%
|
70.34
|
| Net Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.85
+133.70%
|
0.36
|
0.00
-100.00%
|
1.55
|
| Net Other Financing Charges |
|
6.44
+569.31%
|
-1.37
|
—
|
—
|
| Changes In Cash |
|
-3.85
-11769.70%
|
0.03
+100.10%
|
-32.82
-624.01%
|
6.26
|
| Effect Of Exchange Rate Changes |
|
0.02
+121.28%
|
-0.09
+53.23%
|
-0.20
+68.45%
|
-0.64
|
| Beginning Cash Position |
|
10.63
-0.57%
|
10.70
-75.53%
|
43.72
+14.77%
|
38.09
|
| End Cash Position |
|
6.80
-36.02%
|
10.63
-0.57%
|
10.70
-75.53%
|
43.72
|
| Free Cash Flow |
|
-46.62
+29.04%
|
-65.70
+36.03%
|
-102.69
+61.21%
|
-264.75
|
| Interest Paid Supplemental Data |
|
5.04
-37.00%
|
8.00
+20.45%
|
6.64
+521.63%
|
1.07
|
| Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-03 View
- 10-K2026-03-27 View
- 8-K2026-03-27 View
- 8-K2026-01-06 View
- 10-Q2025-11-13 View
- 8-K2025-11-13 View
- 42025-09-12 View
- 10-Q2025-08-13 View
- 8-K2025-08-13 View
- 8-K2025-07-31 View
- 42025-05-29 View
- 42025-05-29 View
- 42025-05-29 View
- 42025-05-29 View
- 8-K2025-05-28 View
- 8-K2025-05-27 View
- 8-K2025-05-22 View
- 10-Q2025-05-13 View
- 8-K2025-05-13 View
- 42025-04-28 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|